Nanjing Vazyme Biotech Salute del bilancio
Salute finanziaria criteri di controllo 4/6
Nanjing Vazyme Biotech has a total shareholder equity of CN¥3.9B and total debt of CN¥500.9M, which brings its debt-to-equity ratio to 12.7%. Its total assets and total liabilities are CN¥4.9B and CN¥959.4M respectively.
Informazioni chiave
12.7%
Rapporto debito/patrimonio netto
CN¥500.92m
Debito
| Indice di copertura degli interessi | n/a |
| Contanti | CN¥2.47b |
| Patrimonio netto | CN¥3.94b |
| Totale passività | CN¥959.43m |
| Totale attività | CN¥4.90b |
Aggiornamenti recenti sulla salute finanziaria
Nessun aggiornamento
Recent updates
Analisi della posizione finanziaria
Passività a breve termine: 688105's short term assets (CN¥3.4B) exceed its short term liabilities (CN¥731.2M).
Passività a lungo termine: 688105's short term assets (CN¥3.4B) exceed its long term liabilities (CN¥228.2M).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: 688105 has more cash than its total debt.
Riduzione del debito: 688105's debt to equity ratio has reduced from 18% to 12.7% over the past 5 years.
Copertura del debito: 688105's debt is not well covered by operating cash flow (14.3%).
Copertura degli interessi: Insufficient data to determine if 688105's interest payments on its debt are well covered by EBIT.